Résultats de la recherche - 64 results
The European response to the WHO call cervical cancer as a public health problem
post‐epidemic phase, health professionals should focus on high‐risk women and adhere to cost‐effective policies including self‐sampling. Health Topics: Quality of healthcare Qualité des soins de santé Kwaliteit ...
The Belgian DNA Debate: An Online Deliberative Platform on the Ethical, Legal, and Social Issues of Genomics
healthcare Qualité des soins de santé Kwaliteit van de gezondheidszorg Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: https://doi.org/10.1159/000515356 File: Version: ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
validating SARS-CoV-2 assays and by bringing modellers together in the COVID-19 and Cancer Taskforce Global Modelling Consortium. Health Topics: Quality of healthcare Cancer Qualité des soins de santé ...
Des patients cancéreux parlent du ngs: Étude de groupe de discussion sur les expériences et les besoins en information
Participation personalised medicine Health Topics: Quality of healthcare Cancer Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Kanker Service: Centre du cancer Kankercentrum Cancer centre ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
testing, dual staining has similar sensitivity. Health Topics: Quality of healthcare Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Cancer Kanker Service: Centre du cancer Kankercentrum ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
seul frottis anormal doit être testé et testé avec le test HPV ou la coloration double p16 / Ki67. Health Topics: Quality of healthcare Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
HPV-based screening. Co-testing can also be carried out. Women between the ages of 20 and 35 should have cytological screening every 2 years. Health Topics: Quality of healthcare Cancer Qualité des soins de ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
a greater impact on women 30 years old or older than younger women. Women with NILM cytology and HPV-16/18 need specific follow-up management within screening. Health Topics: Quality of healthcare Qualité ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
rehabilitation programs. Health Topics: Quality of healthcare Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Cancer Kanker Service: Sciensano & Influenza Sciensano & Influenza ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
future decision-making in cervical cancer control. Health Topics: Quality of healthcare Cancer Qualité des soins de santé Kwaliteit van de gezondheidszorg Cancer Kanker Service: Centre du cancer ...